209 related articles for article (PubMed ID: 11011809)
1. Low-molecular-weight heparin in the treatment of venous thromboembolism.
Hull RD; Pineo GF
Semin Thromb Hemost; 2000; 26 Suppl 1():61-7. PubMed ID: 11011809
[TBL] [Abstract][Full Text] [Related]
2. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.
Gould MK; Dembitzer AD; Doyle RL; Hastie TJ; Garber AM
Ann Intern Med; 1999 May; 130(10):800-9. PubMed ID: 10366369
[TBL] [Abstract][Full Text] [Related]
4. Outpatient management of venous thromboembolism.
Vanscoy GJ
J Thromb Thrombolysis; 1999 Apr; 7(2):109-12. PubMed ID: 10364775
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.
Quinlan DJ; McQuillan A; Eikelboom JW
Ann Intern Med; 2004 Feb; 140(3):175-83. PubMed ID: 14757615
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis.
Gould MK; Dembitzer AD; Sanders GD; Garber AM
Ann Intern Med; 1999 May; 130(10):789-99. PubMed ID: 10366368
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparins: are they superior to unfractionated heparins to prevent and to treat deep vein thrombosis?
Boneu B
Thromb Res; 2000 Oct; 100(2):V113-20. PubMed ID: 11053624
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparins: the optimal treatment for venous thromboembolism.
Daskalopoulos ME; Daskalopoulou SS; Liapis CD
Curr Med Res Opin; 2004 Jul; 20(7):1001-5. PubMed ID: 15265244
[TBL] [Abstract][Full Text] [Related]
9. Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism.
Pineo GF; Hull RD
Baillieres Clin Haematol; 1998 Sep; 11(3):621-37. PubMed ID: 10331096
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic therapy for the management of thrombosis: unfractionated heparin or low-molecular-weight heparin?
Spyropoulos AC
Clin Cornerstone; 2005; 7(4):39-48. PubMed ID: 16758651
[TBL] [Abstract][Full Text] [Related]
11. Unfractionated heparin and low-molecular-weight heparin for the initial treatment of acute venous thromboembolism.
Prandoni P
Haemostasis; 1998; 28 Suppl 3():85-90. PubMed ID: 10069766
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
[TBL] [Abstract][Full Text] [Related]
13. New developments in the prevention and treatment of venous thromboembolism.
Pineo GF;
Pharmacotherapy; 2001 Jun; 21(6 Pt 2):51S-55S; discussion 71S-72S. PubMed ID: 11401193
[TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight heparins in the treatment of deep-vein thrombosis.
Martineau P; Tawil N
Ann Pharmacother; 1998 May; 32(5):588-98, 601. PubMed ID: 9606481
[TBL] [Abstract][Full Text] [Related]
15. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].
Valiukiene L; Naudziūnas A; Unikauskas A
Medicina (Kaunas); 2003; 39(4):352-8. PubMed ID: 12738903
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
Prandoni P; Simioni P; Pagnan A
Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
[TBL] [Abstract][Full Text] [Related]
17. Safety profile of different low-molecular weight heparins used at therapeutic dose.
Gouin-Thibault I; Pautas E; Siguret V
Drug Saf; 2005; 28(4):333-49. PubMed ID: 15783242
[TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
Hauer KE
West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
[TBL] [Abstract][Full Text] [Related]
19. Tinzaparin: excess mortality in elderly patients with renal failure. Unfractionated heparin is best in this setting.
Prescrire Int; 2009 Oct; 18(103):216. PubMed ID: 19882795
[No Abstract] [Full Text] [Related]
20. Current perspectives on the treatment of venous thromboembolism: need for effective, safe and convenient new antithrombotic drugs.
O'Shaughnessy DF
Int J Clin Pract; 2004 Mar; 58(3):277-84. PubMed ID: 15117096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
